Nath Bio-Genes (India) Ltd

📅 Nath Bio-Genes Q2 & H1 FY2026 Results: Board Meeting on Nov 13

- Board meeting scheduled for 13th November 2025 to approve unaudited financial results for the quarter and half year ended 30th September 2025.

- Meeting will consider standalone and consolidated financial results.

- Trading window closed from 30th September 2025 to 16th November 2025 as per insider trading regulations.

- Company name: Nath Bio-Genes (India) Limited.

- BSE Code: 537291, NSE Code: NATHBIOGEN.